Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.
SKU | RCLST000101 |
---|---|
CAS number | 1195765-45-7 |
Molecular Formula | C23H20F3N5O2S2 |
Catalog Number | RCLST000101 |
Chemical Name | Dabrafenib |
Molecular Weight | 519.56 |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Stability | No Data Available |
Appearance | White to Off-White Solid |
Storage Condition | Amber Vial, -20°C Freezer, Under inert atmosphere |